Concomitant autoimmunity in myasthenia gravis - Lack of association with IgA deficiency

Journal of Neuroimmunology

Volumn 236, Issue 1-2, 2011, Pages 118-122

  Ramanujam, Ryan ^a   Piehl, Fredrik ^a   Pirskanen, Ritva ^a   Gregersen, Peter K ^b   Hammarström, Lennart ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Concomitant autoimmunity; IgA deficiency; Myasthenia gravis

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; COHORT ANALYSIS; COLLAGEN DISEASE; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ETHNIC GROUP; GLOMERULONEPHRITIS; HAPLOTYPE; HLA TYPING; HUMAN; HYPERTHYROIDISM; IMMUNOGLOBULIN A DEFICIENCY; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; MYOCARDITIS; MYOKYMIA; MYOSITIS; POLYMERASE CHAIN REACTION; POLYSEROSITIS; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SJOEGREN SYNDROME; SWEDISH; SYSTEMIC LUPUS ERYTHEMATOSUS; TEMPORAL ARTERITIS; THYMECTOMY; ULCERATIVE COLITIS; VASCULITIS;

ADULT; COHORT STUDIES; HAPLOTYPES; HUMANS; IGA DEFICIENCY; MIDDLE AGED; MYASTHENIA GRAVIS; POLYMORPHISM, SINGLE NUCLEOTIDE; REGISTRIES;

EID: 79960180176     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.05.008     Document Type: Article

References (49)

1. Ammann A.J., Hong R. Selective IgA deficiency: presentation of 30 cases and a review of the literature. Medicine 1971, 50(3):223-236.
2. Bachmann R. Studies on the serum gamma-A-globulin level. 3. The frequency of A-gamma-A-globulinemia. Scand. J. Clin. Lab. Investig. 1965, 17(4):316-320.
3. Behan P.O., Simpson J.A., Behan W.M. Letter: decreased serum-IgA in myasthenia gravis. Lancet 1976, 1(7959):593-594.
4. Bettencourt B.F., et al. Evaluation of two methods for computational HLA haplotypes inference using a real dataset. BMC Bioinforma. 2008, 9:68.
5. Bhinder S., Majithia V., Harisdangkul V. Myasthenia gravis and systemic lupus erythematosus: truly associated or coincidental-two case reports and review of the literature. Clin. Rheumatol. 2006, 25(4):555-556.
6. Bramis J., et al. Serum-IgA in myasthenia gravis. Lancet 1976, 307(7971):1243-1244.
7. Castelli E.C., et al. Evaluation of computational methods for the reconstruction of HLA haplotypes. Tissue Antigens 2010, 76(6):459-466.
8. Christensen P.B., et al. Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurol. Scand. 1995, 91(3):192-195.
9. Compston D.A., Vincent A., et al. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 1980, 103(3):579-601.
10. Congia M., et al. A gene dosage effect of the DQA1*0501/DQB1*0201 allelic combination influences the clinical heterogeneity of celiac disease. Hum. Immunol. 1994, 40(2):138-142.
11. Cucca F., et al. Evaluation of IgA deficiency in Sardinians indicates a susceptibility gene is encoded within the HLA class III region. Clin. Exp. Immunol. 1998, 111(1):76-80.
12. de Bakker P.I.W., et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet. 2006, 38(10):1166-1172.
13. Drachman D.B. Myasthenia gravis. N Engl J. Med. 1994, 330(25):1797-1810.
14. Farid N.R., Barnard J.M., Marshall W.H. The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease. Tissue Antigens 1976, 8(3):181-189.
15. Ferreira R.C., et al. Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat. Genet. 2010, 42(9):777-780.
16. Gerli R., et al. Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J. Allergy Clin. Immunol. 1999, 103(5 Pt 1):865-872.
17. Giraud M., Vandiedonck C., Garchon H.-J. Genetic factors in autoimmune myasthenia gravis. Ann. NY Acad. Sci. 2008, 1132:180-192.
18. Hammarström L., Smith C.I. Genetic approach to common variable immunodeficiency and IgA deficiency. Primary Immunodeficiency Diseases: A Molecular and Genetic Approach 2007, 313-325. Oxford University Press, Oxford.
19. Hrycek A. Systemic lupus erythematosus and myasthenia gravis. Pol. Arch. Med. Wewn. 2009, 119(9):582-585.
20. Johansson A., et al. Genetic origin of the Swedish Sami inferred from HLA class I and class II allele frequencies. Eur. J. Human. Genet. 2008, 16(11):1341-1349.
21. Jorgensen G.H., et al. Familial aggregation of IgAD and autoimmunity. Clin. Immunol. (Orlando, Fla.) 2009, 131(2):233-239.
22. Kanazawa M., et al. Clinical features of patients with myasthenia gravis associated with autoimmune diseases. Eur. J. Neurol. 2007, 14(12):1403-1404.
23. Leite M.I., Jacob S., et al. IgG1 antibodies to acetylcholine receptors in "seronegative" myasthenia gravis. Brain 2008, 131(Pt 7):1940-1952.
24. Leslie S., Donnelly Peter, McVean Gil A statistical method for predicting classical HLA alleles from SNP data. Am. J. Hum. Genet. 2008, 82(1):48-56.
25. Liblau R., et al. The frequency of selective IgA deficiency in myasthenia gravis. Neurology 1992, 42(3 Pt 1):516-518.
26. Lisak Robert P. Handbook of myasthenia gravis and myasthenic syndromes 1994, Marcel Dekker.
27. Lisak R.P., Zweiman B. Serum immunogloblin levels in myasthenia gravis, polymyositis, and dermatomyositis. J. Neurol. Neurosurg. Psychiatry 1976, 39(1):34-37.
28. Marinó M., et al. Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J. Clin. Endocrinol. Metab. 1997, 82(2):438-443.
29. McGowan K.E., Lyon M.E., Butzner J.D. Celiac disease and IgA deficiency: complications of serological testing approaches encountered in the clinic. Clin. Chem. 2008, 54(7):1203-1209.
30. Mevorach D., Perrot S., Buchanan N.M., Khamashta M., Laoussadi S., Hughes G.R., Menkes C.J. Appearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature. Lupus 1995, 4(1):33-37.
31. Mohammadi J., et al. Human leukocyte antigens (HLA) associated with selective IgA deficiency in Iran and Sweden. Iran. J. Allergy Asthma Immunol. 2008, 7(4):209-214.
32. Mohammadi J., et al. IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotype. J. Clin. Immunol. 2010, 30(1):138-143.
33. Monden Y., et al. Clinical characteristics and prognosis of myasthenia gravis with other autoimmune diseases. Ann. Thorac. Surg. 1986, 41(2):189-192.
34. Olerup O., Aldener A., Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993, 41(3):119-134.
35. Omar H.A., et al. Systemic lupus erythematosus after thymectomy for myasthenia gravis: a case report and review of the literature. Clin. Exp. Nephrol. 2010, 14(3):277.
36. Pirskanen R. Genetic aspects in myasthenia gravis. A family study of 264 Finnish patients. Acta Neurol. Scand. 1977, 56(5):365-388.
37. Rankin E.C., Isenberg D.A. IgA deficiency and SLE: prevalence in a clinic population and a review of the literature. Lupus 1997, 6(4):390-394.
38. Rioux J.D., et al. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc. Natl. Acad. Sci. U.S.A. 2009, 106(44):18680-18685.
39. Ryser O., Morell A., Hitzig W.H. Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. J. Clin. Immunol. 1988, 8(6):479-485.
40. Sahay B.M., Blendis L.M., Greene R. Relation between myasthenia gravis and thyroid disease. Br. Med. J. 1965, 1(5437):762-765.
41. Simpson J. Myasthenia gravis, a new hypothesis. Scot. Med. J. 1960, 5:419-436.
42. Skarsvåg S., et al. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non[DRB1*03, DQA1*0501, DQB1*0201] class II homozygotes?. Tissue Antigens 1992, 40(3):128-133.
43. Smith W.I., et al. Immunopathology of juvenile-onset diabetes mellitus. I. IgA deficiency and juvenile diabetes. Diabetes 1978, 27(11):1092-1097.
44. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 2001, 68(4):978-989.
45. Toth C., et al. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease. Acta Neurol. Scand. 2006, 114(2):124-132.
46. Vaiopoulos G., et al. The association of systemic lupus erythematosus and myasthenia gravis. Postgrad. Med. J. 1994, 70(828):741-745.
47. Vincent Angela, et al. Myasthenia gravis seronegative for acetylcholine receptor antibodies. Ann. NY Acad. Sci. 2008, 1132:84-92.
48. Wetherall J.D., Robinson J., Dawkins R.L. Serum-Iga in myasthenia gravis. Lancet 1976, 2(7986):637.
49. Zonana M.F., Reyes E., Weisman A.K. Coexistence of four autoimmune diseases in one patient: the kaleidoscope of autoimmunity. J. Clin. Rheumatol. 2002, 8(6):322-325.